Skip to main content
iwCLL 2025 Main banner
Final Program


Save The Date

    (1717) MVA-Based GEO-CM04S1 Vaccine Results in Improved Cellular Immune Response in Patients With Chronic Lymphocytic Leukemia (CLL) Compared With mRNA-Based Vaccine: Initial Results of a Phase II Randomized Study

    Sunday, September 14, 2025
    15:40 - 15:45 CEST
    Location: ICE, Auditorium Hall (S1), Entrances On Level 0 & 1
    Oral P

      Primary Author / Presenter(s)

    • Alexey V. Danilov, MD, PhD

      Professor
      Department of Hematology and Transplantation, City of Hope National Medical Center
      Duarte, California, United States